Literature DB >> 2843663

Bovine papillomavirus E2 gene regulates expression of the viral E5 transforming gene.

S S Prakash1, B H Horwitz, T Zibello, J Settleman, D DiMaio.   

Abstract

We have performed transient-expression experiments with CV1 monkey kidney cells to investigate the role of the bovine papillomavirus type 1 (BPV1) E2 gene in the regulation of the E5 transforming gene. Direct analysis of the 7-kilodalton open reading frame (ORF) E5 protein and measurements of the expression of an E5-chloramphenicol acetyltransferase fusion protein indicate that the efficient expression of ORF E5 requires the full-length E2 gene, which can be supplied in trans. The viral long control region is required in cis for this response to ORF E2, and it acts in a position- and orientation-independent fashion characteristic of a transcriptional enhancer. Deletion analysis suggests that the P2443 promoter is required for efficient expression of the E5 gene. The E2 repressor activity encoded in the 3' end of the E2 gene inhibits the expression of ORF E5. These effects define a major BPV1 regulatory circuit and appear to explain the transformation behavior of a variety of BPV1 mutants.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2843663      PMCID: PMC253501          DOI: 10.1128/JVI.62.10.3608-3613.1988

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA.

Authors:  D R Lowy; I Dvoretzky; R Shober; M F Law; L Engel; P M Howley
Journal:  Nature       Date:  1980-09-04       Impact factor: 49.962

2.  Transformation and replication in mouse cells of a bovine papillomavirus--pML2 plasmid vector that can be rescued in bacteria.

Authors:  N Sarver; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

3.  Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate.

Authors:  C M Gorman; B H Howard; R Reeves
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

4.  A quantitative in vitro focus assay for bovine papilloma virus.

Authors:  I Dvoretzky; R Shober; S K Chattopadhyay; D R Lowy
Journal:  Virology       Date:  1980-06       Impact factor: 3.616

5.  The primary structure and genetic organization of the bovine papillomavirus type 1 genome.

Authors:  E Y Chen; P M Howley; A D Levinson; P H Seeburg
Journal:  Nature       Date:  1982-10-07       Impact factor: 49.962

6.  Bovine papillomavirus vector that propagates as a plasmid in both mouse and bacterial cells.

Authors:  D DiMaio; R Treisman; T Maniatis
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

7.  Identification of a second transforming region in bovine papillomavirus DNA.

Authors:  J T Schiller; W C Vass; D R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

8.  Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.

Authors:  C M Gorman; L F Moffat; B H Howard
Journal:  Mol Cell Biol       Date:  1982-09       Impact factor: 4.272

9.  Genetic and biochemical definition of the bovine papillomavirus E5 transforming protein.

Authors:  A Burkhardt; D DiMaio; R Schlegel
Journal:  EMBO J       Date:  1987-08       Impact factor: 11.598

10.  Bovine papillomavirus mutant temperature sensitive for transformation, replication and transactivation.

Authors:  D DiMaio; J Settleman
Journal:  EMBO J       Date:  1988-04       Impact factor: 11.598

View more
  26 in total

1.  A constitutive enhancer in the bovine papillomavirus upstream regulatory region shares genetic elements with the viral P1 promoter.

Authors:  G L Bream; P Vaillancourt; M R Botchan
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  The activation domain of the bovine papillomavirus E2 protein mediates association of DNA-bound dimers to form DNA loops.

Authors:  J D Knight; R Li; M Botchan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Cooperative binding of the E2 protein of bovine papillomavirus to adjacent E2-responsive sequences.

Authors:  P Monini; S R Grossman; B Pepinsky; E J Androphy; L A Laimins
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

4.  Bovine papillomavirus E2 repressor mutant displays a high-copy-number phenotype and enhanced transforming activity.

Authors:  D J Riese; J Settleman; K Neary; D DiMaio
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

5.  Efficient transactivation and morphologic transformation by bovine papillomavirus genes expressed from a bovine papillomavirus/simian virus 40 recombinant virus.

Authors:  J Settleman; D DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

6.  Enhanced transcriptional activation by E2 proteins from the oncogenic human papillomaviruses.

Authors:  R Kovelman; G K Bilter; E Glezer; A Y Tsou; M S Barbosa
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

7.  Genetic evidence that acute morphologic transformation, induction of cellular DNA synthesis, and focus formation are mediated by a single activity of the bovine papillomavirus E5 protein.

Authors:  J Settleman; A Fazeli; J Malicki; B H Horwitz; D DiMaio
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

8.  Characterization of the cis elements involved in basal and E2-transactivated expression of the bovine papillomavirus P2443 promoter.

Authors:  B A Spalholz; S B Vande Pol; P M Howley
Journal:  J Virol       Date:  1991-02       Impact factor: 5.103

9.  Differentiation-specific expression from the bovine papillomavirus type 1 P2443 and late promoters.

Authors:  S K Barksdale; C C Baker
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

10.  Regulation of early gene expression from the bovine papillomavirus genome in transiently transfected C127 cells.

Authors:  P Szymanski; A Stenlund
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.